Palmoplantar keratoderma

DBCOND0020029Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin and Subcutaneous Tissue Diseases

Palmoplantar keratoderma is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Keratosis Palmaris et Plantaris · Palmoplantar Keratoses
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT022963ICD-10L85.2SNOMED CT205584004MedDRA10033554UMLSC0022596

What you can answer from here — as of October 19, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Palmoplantar keratoderma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In